|
KIAA1328 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.615100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.491000E-01 |
| Normal-vs-Stage2 |
9.190600E-01 |
| Normal-vs-Stage3 |
1.07029999973918E-07 |
| Normal-vs-Stage4 |
9.93400028903579E-10 |
| Stage1-vs-Stage2 |
7.378000E-01 |
| Stage1-vs-Stage3 |
7.8487000010341E-08 |
| Stage1-vs-Stage4 |
4.7130999103473E-10 |
| Stage2-vs-Stage3 |
3.537700E-02 |
| Stage2-vs-Stage4 |
1.051690E-02 |
| Stage3-vs-Stage4 |
1.552640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.102000E-03 |
| Normal-vs-AfricanAmerican |
3.728500E-02 |
| Normal-vs-Asian |
9.147200E-01 |
| Caucasian-vs-AfricanAmerican |
7.373400E-01 |
| Caucasian-vs-Asian |
5.639200E-01 |
| AfricanAmerican-vs-Asian |
4.261800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.778300E-03 |
| Normal-vs-Female |
5.231600E-02 |
| Male-vs-Female |
4.592800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.277700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.272410E-01 |
| Normal-vs-Age(61-80Yrs) |
2.236100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.958000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.481410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.096800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.428600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.461400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.644000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.184600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.291600E-02 |
| Normal-vs-Grade 2 |
8.800200E-01 |
| Normal-vs-Grade 3 |
4.43829999996481E-06 |
| Normal-vs-Grade 4 |
2.07323047618502E-12 |
| Grade 1-vs-Grade 2 |
2.509600E-01 |
| Grade 1-vs-Grade 3 |
8.17870000000553E-05 |
| Grade 1-vs-Grade 4 |
2.71379996252819E-09 |
| Grade 2-vs-Grade 3 |
1.567289999993E-05 |
| Grade 2-vs-Grade 4 |
2.06223926824123E-12 |
| Grade 3-vs-Grade 4 |
2.12749999999318E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.968600E-01 |
| Normal-vs-ccB subtype |
6.018500E-02 |
| ccA subtype-vs-ccB subtype |
9.596100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.691500E-02 |
| Normal-vs-N1 |
1.54472999999156E-05 |
| N0-vs-N1 |
2.505000E-03 |
|
|
